Received Dec 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
body aches; This is a spontaneous report received from a Consumer or other non HCP, Program ID:. A 72-year-old female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 02Dec2025 as dose 1, single (Batch/Lot number: unknown) at the age of 72 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ELIQUIS; HYDROXYZINE HCL; IMODIUM A-D; LETROZOLE; LEVOTHYROXINE SODIUM; LOVASTATIN; MELOXICAM; METHOCARBAMOL; NOVOLOG MIX 70/30; ONDANSETRON HCL; OXYCODONE AND ACETAMINOPHEN; TRESIBA FLEXTOUCH; VITAMIN D3; WOMENS MULTI ONE A DAY; ZARXIO. Past drug history included: Morphine, reaction(s): "drug allergy"; Codeine, reaction(s): "drug allergy". The following information was reported: PAIN (non-serious) with onset Dec2025, outcome "not recovered", described as "body aches". It was unknown if therapeutic measures were taken as a result of pain. Additional information: Not feeling the best after receiving Covid vaccine on 2-DEC. States mainly having body aches. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
ELIQUIS; HYDROXYZINE HCL; IMODIUM A-D; LETROZOLE; LEVOTHYROXINE SODIUM; LOVASTATIN; MELOXICAM; METHOCARBAMOL; NOVOLOG MIX 70/30; ONDANSETRON HCL; OXYCODONE AND ACETAMINOPHEN; TRESIBA FLEXTOUCH; VITAMIN D3; WOMENS MULTI ONE A DAY; ZARXIO